Literature DB >> 2409757

Calcium dependent modulation of histamine release from mast cells by sodium and potassium.

M Binck, N Frossard, Y Landry.   

Abstract

The inhibition of sodium-potassium ATPase by ouabain or potassium-deprivation led to a potentiation of histamine release induced by antigen or compound 48/80 from rat mast cells. The fullest potentiation required 30 min preincubation of cells with ouabain or without potassium before adding the triggering agent. The potentiation was observed provided that the calcium concentration was less than 0.5 mM. The effect of sodium-potassium ATPase blockade was reversed slowly by washing out ouabain or by adding potassium. Metabolic inhibition with deoxyglucose and dinitrophenol-blocked histamine release observed under all conditions described. Histamine release from rat mast cells was also elicited when the cells were incubated in sodium-deficient media where sodium was replaced by sucrose. Potassium-deprivation potentiated this secretion process previously shown to be dependent upon metabolic energy and sensitive to millimolar calcium concentrations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409757     DOI: 10.1007/bf01983116

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  Dissociation of histamine release and 22Na+ uptake in rat mast cells exposed to compound 48/80 in vitro.

Authors:  S A Slorach; B Uvnäs
Journal:  Acta Physiol Scand       Date:  1969 May-Jun

2.  Sodium-potassium ATPase, calcium, and immunological histamine release.

Authors:  N Frossard; M Amellal; Y Landry
Journal:  Biochem Pharmacol       Date:  1983-11-01       Impact factor: 5.858

3.  Crosslinking of the receptors for immunoglobulin E depolarizes the plasma membrane of rat basophilic leukemia cells.

Authors:  B I Kanner; H Metzger
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

4.  Histamine release by exocytosis from rat mast cells on reduction of extracellular sodium: a secretory response inhibited by calcium, strontium, barium or magnesium.

Authors:  D E Cochrane; W W Douglas
Journal:  J Physiol       Date:  1976-05       Impact factor: 5.182

5.  Membrane potential changes during IgE-mediated histamine release from rat basophilic leukemia cells.

Authors:  R Sagi-Eisenberg; I Pecht
Journal:  J Membr Biol       Date:  1983       Impact factor: 1.843

6.  Sodium-potassium ATPase inhibition potentiates compound 48/80-induced histamine secretion from mast cells.

Authors:  M Amellal; M Binck; N Frossard; B Ilien; Y Landry
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

7.  Calcium efflux and histamine secretion from rat peritoneal mast cells.

Authors:  F L Pearce; J R White
Journal:  Agents Actions       Date:  1984-04
  7 in total
  6 in total

1.  Changes in rat mast cell responses in sodium-free media. Lack of demonstrable sodium channel activity.

Authors:  M R Vieytes; A Alfonso; M J Bujan; M C Louzao; A Cavado; L F de la Cruz; L M Botana
Journal:  Agents Actions       Date:  1991-05

2.  Inhibition of Na(+) -K+ pump activity by divalent cations in intact peritoneal mast cells of the rat.

Authors:  T Knudsen; H C Berthelsen; T Johansen
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

3.  The mode of inhibition of the Na+-K+ pump activity in mast cells by calcium.

Authors:  T Knudsen; T Johansen
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

4.  Transmembrane sodium and potassium gradients modulate histamine secretion induced by ionophore A23187.

Authors:  M Amellal; C Bronner; Y Landry
Journal:  Br J Pharmacol       Date:  1985-08       Impact factor: 8.739

5.  Valinomycin, a degranulating agent in rat mast cells which inhibits calcium-uptake.

Authors:  N Eleno; L Botana; C Segura; J Espinosa
Journal:  Agents Actions       Date:  1987-12

6.  Na+ -K+ pump activity in rat peritoneal mast cells: inhibition by extracellular calcium.

Authors:  T Knudsen; T Johansen
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.